Johnson & Johnson Wins FDA Approval For Surgical Robot Ottava After Years Of Development
Product·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Johnson & Johnson has received FDA approval for its new surgical robot, Ottava, after years of development and significant investment. The approval raises questions about whether Ottava can compete with established rivals in the surgical robotics market.
The company has reportedly spent hundreds of millions of dollars on the development of Ottava. Analysts are now considering if the market is already dominated by competitors who entered the race years earlier.
Johnson & Johnson
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“After spending years and hundreds of millions of dollars, Johnson and Johnson has won FDA approval for its new surgical robot Ottava.”
Bloomberg — This Surgical Robot Could Transform the Operating Room